---
id: 205
title: Necrotizing Fasciitis
category: clinical_syndromes
subcategory: skin_soft_tissue
tags: [necrotizing-fasciitis, NSTI, Group-A-Strep, clindamycin, surgical-debridement, pain-out-of-proportion]
difficulty: high
---

## Question

How is necrotizing fasciitis managed? Use **"Pain >> Exam, Bullae, Crepitus → Urgent Surgery + Vanc + Pip-Tazo + Clinda, IVIG for Strep TSS"** framework.

## Answer

### **Types:**

**Type I (Polymicrobial, 70-80%):**
- **Organisms:** Mixed aerobic + anaerobic (Gram-negatives + strep + anaerobes)
- **Risk factors:** Diabetes, obesity, peripheral vascular disease, immunosuppression

**Type II (Monomicrobial, 20-30%):**
- ***Streptococcus pyogenes* (Group A Strep)** - most common
- ***S. aureus* (MSSA/MRSA)**
- ***Vibrio vulnificus*** (seawater exposure, shellfish, cirrhosis)
- ***Aeromonas hydrophila*** (freshwater exposure)

**Type III (Fungal, Rare):**
- **Mucormycosis** (immunocompromised)

### **Clinical Presentation:**

**Early (<24h):**
- **Pain out of proportion** to physical findings (HALLMARK)
- **Erythema, warmth, swelling** (mimics cellulitis)
- **Fever, tachycardia**

**Late (24-72h):**
- **Bullae** (hemorrhagic, fluid-filled)
- **Skin necrosis** (dusky, purple, black)
- **Crepitus** (gas in soft tissues, especially if anaerobes/Clostridium)
- **Anesthesia** (nerve destruction)
- **Systemic toxicity:** Hypotension, AMS, multiorgan failure

**Toxic Shock Syndrome (If Group A Strep):**
- **Hypotension, multiorgan failure** (ARDS, AKI, DIC)
- **Desquamating rash** (palms, soles)

### **Diagnosis:**

**Clinical (High Suspicion = Surgical Exploration):**
- **Do NOT wait for imaging** if clinical suspicion high

**LRINEC Score (Laboratory Risk Indicator for Necrotizing Fasciitis):**
- **Points:** CRP, WBC, Hb, Na, Cr, glucose
- **Score ≥6:** Suggests NSTI (but NOT definitive, do NOT use alone)
- **Low score does NOT exclude** NSTI

**Imaging (If Diagnosis Uncertain):**
- **CT/MRI:** Gas in soft tissues, fascial thickening, fluid tracking along fascial planes
- **NOT sensitive** early (do NOT delay surgery for imaging)

**Surgical Exploration (Gold Standard):**
- **"Finger test":** Blunt dissection along fascia (if easy dissection with minimal resistance + dishwater pus = NSTI)
- **Tissue biopsy:** Necrosis, vascular thrombosis, organisms on Gram stain

### **Treatment:**

**1. URGENT SURGICAL DEBRIDEMENT (LIFE-SAVING):**
- **Within 6-12 hours** (every hour delay ↑mortality)
- **Wide excision** of all necrotic tissue (often requires amputation)
- **Repeat surgeries** (24-48h intervals) until no further necrosis

**2. Empiric Antibiotics (Immediately):**

**Type I (Polymicrobial):**
- **Vancomycin 15-20 mg/kg IV q8-12h** + **piperacillin-tazobactam 3.375-4.5g IV q6-8h** + **clindamycin 900mg IV q8h**
- OR **vancomycin** + **carbapenem** (meropenem 1g IV q8h) + **clindamycin**

**Type II (*S. pyogenes*):**
- **Penicillin G 4 million units IV q4h** + **clindamycin 900mg IV q8h**
- **Clindamycin ESSENTIAL** (inhibits toxin production, effective in stationary phase)

***Vibrio vulnificus*:**
- **Doxycycline 100mg IV q12h** + **ceftriaxone 2g IV q12h**

**Duration:** 7-14 days (until debridement complete + clinically stable)

**3. Adjunctive Therapy:**

**IVIG (If Streptococcal TSS):**
- **IVIG 2 g/kg IV × 1** (single dose)
- **Neutralizes superantigens/toxins**
- **Consider if:** Hypotension, multiorgan failure, Group A Strep

**Hyperbaric Oxygen (Controversial):**
- **May reduce tissue loss** (improves oxygenation, inhibits toxin production)
- **NOT substitute for surgery**
- **Consider as adjunct** if available

**4. Supportive Care:**
- **Aggressive fluid resuscitation** (shock common)
- **Vasopressors** (if needed)
- **ICU monitoring**

### **Microbiology:**

***Streptococcus pyogenes* (Group A Strep):**
- **M protein types** 1, 3, 12, 28 (associated with invasive disease, TSS)
- **Exotoxins:** Pyrogenic exotoxin A, B (superantigens → TSS)

***Vibrio vulnificus*:**
- **Risk:** Cirrhosis, hemochromatosis, immunosuppression, seawater exposure (Gulf Coast, raw oysters)
- **Bullous skin lesions** (hemorrhagic)
- **High mortality** (50%)

***Aeromonas hydrophila*:**
- **Freshwater exposure** (lakes, rivers)
- **Leeches** (can transmit)

**Clostridial Myonecrosis (Gas Gangrene):**
- **Different from necrotizing fasciitis** (muscle involvement, NO pus, rapidly progressive)
- **See separate card**

### **Mortality:**

**Overall:** 20-40% (despite treatment)

**Risk Factors for Death:**
- **Delayed surgery** (>24h)
- **Age >60 years**
- **Comorbidities** (diabetes, renal failure, cirrhosis)
- **Streptococcal TSS** (>50% mortality)

## Key Points

### **Pain Out of Proportion:**
- **Hallmark** early finding
- **Severe pain** with minimal skin findings
- **High suspicion → surgical exploration**

### **Urgent Surgery = Life-Saving:**
- **Within 6-12 hours** (every hour delay ↑mortality)
- **Wide debridement, repeat surgeries** (24-48h until no necrosis)
- **Often requires amputation**

### **Clindamycin Essential:**
- **Inhibits toxin production** (*S. pyogenes*)
- **Effective in stationary phase** (β-lactams less effective once bacterial growth slows)

### **IVIG for Streptococcal TSS:**
- **2 g/kg IV × 1** (if hypotension, multiorgan failure, Group A Strep)
- **Neutralizes superantigens**

### **Crepitus = Gas in Tissues:**
- **Suggests anaerobes** (*Clostridium*, *Bacteroides*) or Gram-negatives (*E. coli*, *Klebsiella*)
- **NOT specific** for gas gangrene (can occur in NSTI)

### **Clinical Pearls:**
- **Pain >> exam + systemic toxicity** → suspect NSTI
- **URGENT surgery** (within 6-12h) + vanc + pip-tazo + clindamycin
- **Clindamycin essential** (inhibits toxin production)
- **IVIG 2 g/kg** if streptococcal TSS (hypotension, multiorgan failure)
- ***Vibrio*:** Seawater exposure, cirrhosis → doxycycline + ceftriaxone

## Sources

- [IDSA: Skin and Soft Tissue Infection Guidelines 2024]
- [Lancet ID: Necrotizing Fasciitis 2024]

## Media

N/A
